PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för butylscopolamine bromide. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

18 hits

Bibliografisk träff 2019-04-01

Immediate dilation of a tight or stenotic cervix by intra-procedural administration of hyoscine butylbromide: A clinical trial.

Hadadianpour S, Tavana S, Tavana A, Fallahian M.

Int J Reprod Biomed · research-article; journal article · DOI 10.18502/ijrm.v17i4.4550

Bibliografisk träff 2018-12-18

Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome.

Iihara H, Fujii H, Yoshimi C, Kobayashi R, Matsuhashi N, Takahashi T, Yoshida K, Suzuki A.

Cancer Chemother Pharmacol · research-article; journal article · DOI 10.1007/s00280-018-3736-z

Bibliografisk träff 2018-11-26

Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later".

Boland JW, Currow D, Johnson M.

J Pain Symptom Manage · letter; comment · DOI 10.1016/j.jpainsymman.2018.11.018

Bibliografisk träff 2018-09-22

Response to Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later.

Campbell ML.

J Pain Symptom Manage · letter; comment · DOI 10.1016/j.jpainsymman.2018.09.013

Bibliografisk träff 2018-08-31

Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later.

Mercadante S, Marinangeli F, Masedu F, Valenti M, Russo D, Ursini L, Massici A, Aielli F.

J Pain Symptom Manage · comparative study; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.jpainsymman.2018.08.018

Retracted publication 2018-08-10

Oral Diclofenac Potassium Versus Hyoscine-N-Butyl Bromide in Reducing Pain Perception during Office Hysteroscopy: ARandomized Double-blind Placebo-controlled Trial.

Abbas AM, Elzargha AM, Ahmed AGM, Mohamed II, Altraigey A, Abdelbadee AY.

J Minim Invasive Gynecol · retracted publication; randomized controlled trial; journal article · DOI 10.1016/j.jmig.2018.08.001

Bibliografisk träff 2018-04-01

Risks in the clinical applications of scopolamine butylbromide injections.

Zheng L, Yang J, Song C.

Int J Clin Pharmacol Ther · journal article · DOI 10.5414/cp203177

Bibliografisk träff 2017-12-27

Scopolamine butylbromide decreases the xylazine-mediated contractility in bovine pregnant uteri.

Sciorsci RL, Piccinno M, Rizzo A.

Theriogenology · journal article · DOI 10.1016/j.theriogenology.2017.12.033

Bibliografisk träff 2017-12-01

Effect of hyoscine butyl-bromide on the duration of active phase of labor: A randomized-controlled trial.

Imaralu JO, Kuti O, Badejoko OO, Loto OM, Olaleye A.

Taiwan J Obstet Gynecol · randomized controlled trial; journal article · DOI 10.1016/j.tjog.2017.10.003

Bibliografisk träff 2017-08-18

Use of intravenous hyoscine butylbromide (Buscopan) during gastrointestinal endoscopy.

Lee T, Anderson J, Thomas-Gibson S, Rees C.

Frontline Gastroenterol · editorial · DOI 10.1136/flgastro-2017-100877

Bibliografisk träff 2017-07-07

Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate.

Ullrich T, Quentin M, Schmaltz AK, Arsov C, Rubbert C, Blondin D, Rabenalt R, Albers P, Antoch G, Schimmöller L.

Eur Radiol · clinical trial; journal article · DOI 10.1007/s00330-017-4940-7

Bibliografisk träff 2017-05-02

MHRA safety alert: hyoscine butylbromide (Buscopan) injection.

Författaruppgift saknas

Drug Ther Bull · journal article · DOI 10.1136/dtb.2017.5.0473

Bibliografisk träff 2016-08-26

Neonatal treatment with scopolamine butylbromide prevents metabolic dysfunction in male rats.

Malta A, Souza AA, Ribeiro TA, Francisco FA, Pavanello A, Prates KV, Tófolo LP, Miranda RA, Oliveira JC, Martins IP, Previate C, Gomes RM, Franco CC, Natali MR, Palma-Rigo K, Mathias PC.

Sci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/srep30745

Bibliografisk träff 2016-03-17

Field use of N-butylscopolammonium bromide to facilitate thorough ophthalmic examination in horses.

Palmero J, Hollingsworth S, Kass P, Moore S, Pusterla N.

Vet J · randomized controlled trial; journal article · DOI 10.1016/j.tvjl.2016.03.013

Bibliografisk träff 2015-04-01

Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series.

Takeuchi I, Suzuki T, Kishi T, Kanamori D, Hanya M, Uno J, Fujita K, Kamei H.

Clin Psychopharmacol Neurosci · journal article; case-report · DOI 10.9758/cpn.2015.13.1.109

Bibliografisk träff 2013-05-19

Effect of hyoscine butylbromide (Buscopan®) on cholinergic pathways in the human intestine.

Krueger D, Michel K, Allam S, Weiser T, Demir IE, Ceyhan GO, Zeller F, Schemann M.

Neurogastroenterol Motil · journal article · DOI 10.1111/nmo.12156

Bibliografisk träff 2012-08-27

Effects of N-butylscopolammonium bromide on lung function in horses with recurrent airway obstruction.

Couetil L, Hammer J, Miskovic Feutz M, Nogradi N, Perez-Moreno C, Ivester K.

J Vet Intern Med · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1111/j.1939-1676.2012.00992.x

Bibliografisk träff 2011-08-01

Cardiovascular effects of N-butylscopolammonium bromide and xylazine in horses.

Morton AJ, Varney CR, Ekiri AB, Grosche A.

Equine Vet J Suppl · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1111/j.2042-3306.2011.00400.x